Interleukin-9 protects from microglia- and TNF-mediated synaptotoxicity in experimental multiple sclerosis
Authors:
Open Access
- 14 May 2024
- journal article
- research article
- Published by Springer Nature in Journal of Neuroinflammation
- Vol. 21 (1) , 1-16
Abstract
Background: Multiple sclerosis (MS) is a progressive neurodegenerative disease of the central nervous system characterized by inflammation-driven synaptic abnormalities. Interleukin-9 (IL-9) is emerging as a pleiotropic cytokine involved in MS pathophysiology. Methods: Through biochemical, immunohistochemical, and electrophysiological experiments, we investigated the effects of both peripheral and central administration of IL-9 on C57/BL6 female mice with experimental autoimmune encephalomyelitis (EAE), a model of MS. Results: We demonstrated that both systemic and local administration of IL-9 significantly improved clinical disability, reduced neuroinflammation, and mitigated synaptic damage in EAE. The results unveil an unrecognized central effect of IL-9 against microglia- and TNF-mediated neuronal excitotoxicity. Two main mechanisms emerged: first, IL-9 modulated microglial inflammatory activity by enhancing the expression of the triggering receptor expressed on myeloid cells-2 (TREM2) and reducing TNF release. Second, IL-9 suppressed neuronal TNF signaling, thereby blocking its synaptotoxic effects. Conclusions: The data presented in this work highlight IL-9 as a critical neuroprotective molecule capable of interfering with inflammatory synaptopathy in EAE. These findings open new avenues for treatments targeting the neurodegenerative damage associated with MS, as well as other inflammatory and neurodegenerative disorders of the central nervous system.Keywords
This publication has 46 references indexed in Scilit:
- Neutralization of IL-9 Ameliorates Experimental Autoimmune Encephalomyelitis by Decreasing the Effector T Cell PopulationThe Journal of Immunology, 2010
- IL-9 induces differentiation of T H 17 cells and enhances function of FoxP3 + natural regulatory T cellsProceedings of the National Academy of Sciences, 2009
- Inflammation Triggers Synaptic Alteration and Degeneration in Experimental Autoimmune EncephalomyelitisJournal of Neuroscience, 2009
- Neurodegeneration in multiple sclerosis: The role of oxidative stress and excitotoxicityJournal of the Neurological Sciences, 2008
- Grey matter pathology in multiple sclerosisThe Lancet Neurology, 2008
- IL-9/IL-9 receptor signaling selectively protects cortical neurons against developmental apoptosisCell Death & Differentiation, 2008
- Blockade of TREM‐2 exacerbates experimental autoimmune encephalomyelitisEuropean Journal of Immunology, 2007
- TREM2-Transduced Myeloid Precursors Mediate Nervous Tissue Debris Clearance and Facilitate Recovery in an Animal Model of Multiple SclerosisPLOS Medicine, 2007
- IL-9 Inhibits Oxidative Burst and TNF-α Release in Lipopolysaccharide-Stimulated Human Monocytes Through TGF-βThe Journal of Immunology, 2002
- Involvement of the Ubiquitin-Proteasome Pathway in the Degradation of Nontyrosine Kinase-Type Cytokine Receptors of IL-9, IL-2, and ErythropoietinThe Journal of Immunology, 2000